WDR19 Gene Cranioectodermal dysplasia type 4 Genetic Test
Introduction
The WDR19 gene is associated with cranioectodermal dysplasia type 4 (CED4), a rare genetic disorder characterized by abnormalities in the development of the craniofacial structures, ectodermal tissues, and skeletal system.
Test Details
The WDR19 Gene Cranioectodermal dysplasia type 4 Genetic Test is a NGS (Next-Generation Sequencing) genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. This test specifically identifies mutations or variants in the WDR19 gene that are associated with CED4.
Components
- Test Name: WDR19 Gene Cranioectodermal dysplasia type 4 Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test type: Dysmorphology
- Doctor: Pediatrics
- Test Department: Genetics
Pre Test Information
Prior to undergoing the WDR19 Gene Cranioectodermal dysplasia type 4 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with the WDR19 Gene Cranioectodermal dysplasia type 4 NGS Genetic DNA Test gene WDR19.
Procedure
The test involves obtaining a DNA sample, usually through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any genetic variations or mutations in the WDR19 gene.
Results and Interpretation
The results of the test can help confirm a diagnosis of CED4 and provide information about the specific genetic variant present. It is crucial to consult with a healthcare professional or genetic counselor to interpret the results and receive appropriate counseling and support for individuals and families affected by CED4.
Test Name | WDR19 Gene Cranioectodermal dysplasia type 4 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Dysmorphology |
Doctor | Pediatrics |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for WDR19 Gene Cranioectodermal dysplasia type 4 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with WDR19 Gene Cranioectodermal dysplasia type 4 NGS Genetic DNA Test gene WDR19 |
Test Details |
The WDR19 gene is associated with cranioectodermal dysplasia type 4 (CED4), a rare genetic disorder characterized by abnormalities in the development of the craniofacial structures, ectodermal tissues, and skeletal system. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of CED4, NGS genetic testing can be used to identify mutations or variants in the WDR19 gene that are associated with the disorder. NGS genetic testing for CED4 involves obtaining a DNA sample, usually through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any genetic variations or mutations in the WDR19 gene. The results of the test can help confirm a diagnosis of CED4 and provide information about the specific genetic variant present. It is important to note that genetic testing for CED4 and other genetic disorders should be done under the guidance of a healthcare professional or genetic counselor. They can help interpret the results of the test and provide appropriate counseling and support for individuals and families affected by CED4. |